HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Cancer Of The Eye

Cancer Of The Eye

Ocular cancer, commonly referred to as eye cancer, represents a relatively uncommon yet formidable challenge in the realm of oncological research. Delving into the intricate mechanisms underlying its onset and progression, scientists probe the interplay between genetic predispositions, environmental triggers, and lifestyle influences. Cutting-edge imaging technologies facilitate early identification, enhancing prognosis and treatment outcomes. From targeted drug therapies to the promising frontier of immunomodulation, the therapeutic landscape is expanding, offering renewed hope for patients. Interdisciplinary collaboration among oncologists, ophthalmologists, and researchers remains pivotal in deciphering ocular cancer's complexities, driving forward strides in prevention, diagnosis, and tailored intervention strategies.

Committee Members
Committee Member - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Committee Member - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp